Eli Lilly and Company (LLY) Price and Market Data
Explore real-time Eli Lilly and Company (LLY) price, market cap, trading volume, and price changes. View the live price chart and key reference data.
Eli Lilly and Company price chart+3.90%1m
Next LLY earnings
October 29, 2026in 15 days
Q3 2026 · Before market open · 3 more in the next 12 months
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
Reference
- Exchange
- NYSE
- Sector
- Drug Manufacturers - General
- Employees
- 50,000
- Listed
- 7/9/1970
- Market cap
- $1.04T
- Shares outstanding
- 944,818,881
- Currency
- USD
- Website
- https://www.lilly.com
